Published by Michele Maatouk on 9th June 2026
(Sharecast News) - GSK said on Tuesday that it has agreed to buy Boston-based oncology-focused biopharmaceutical firm Nuvalent for $10.6bn (£7.9bn).
URL: http://www.digitallook.com/dl/news/story/35987073/...